Research programme: indolocarbazoles - Advanced Life Sciences

Drug Profile

Research programme: indolocarbazoles - Advanced Life Sciences

Alternative Names: ALS-423; ALS-559

Latest Information Update: 06 May 2011

Price : $50

At a glance

  • Originator Advanced Life Sciences
  • Class Carbazoles; Indoles
  • Mechanism of Action DNA topoisomerase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Solid tumours

Most Recent Events

  • 06 May 2011 Suspended - Preclinical for Solid tumours in USA (unspecified route)
  • 09 Jun 2006 This programme is still in active development
  • 30 Sep 2002 Preclinical trials in Solid tumours in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top